cns.jpg (2811 bytes)

Subscription

Reprints

Journal Home
Contents
Editorial Board
Instructions for Contributors
Subscription Rates


© Neva Press, Inc. 2005


CNS Drug Reviews

Table of Contents

Volume 2, No. 4

363 FG 5893: A Potential New Generation Anxiolytic/Antidepressant Drug With High Affinity for both 5HT1A and 5HT2A Receptors
Gunnar Andersson, Agneta Albinsson, Anders Björk and Jan Svartengren
390 Flumazenil
D. Bentué-Ferrer, M. Bureau, A. Patat, H. Allain
415 Pharmacological Properties of a Putative 5HT1B-D Receptor Antagonist GR-127,935
Petrus J. Pauwels
429 Endogenous and Synthetic Cannabinoids: Recent Advances
Esther Shohami, Joseph Weidenfeld, Haim Ovdia, Zvi Vogel, Lumir Hamis, Ester Fride, Aviva Breuer, Shimon Ben-Shabat, Tzviel Sheskin, Raphael Mechoulam
452 Interaction of New and Potential Antiepileptics With Conventional Antiepileptic Drugs in Clinical Trials and Experimental Models of Epilepsy
S. J. Czuszwar, Z. Kleinrok and W. A. Turski
468 SUBJECT INDEX for Volume 2
471 AUTHOR INDEX for Volume 2